Welcome to our dedicated page for Marchex SEC filings (Ticker: MCHX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Marchex, Inc. (NASDAQ: MCHX) SEC filings, offering a detailed view of the company’s regulatory disclosures as a Delaware corporation in the software publishers industry. Through documents such as Forms 8-K, proxy statements (DEF 14A), and other Exchange Act reports, investors can review information on governance, compensation, capital structure, and material agreements.
Recent 8-K filings describe topics including executive leadership changes, compensation arrangements, stock option and restricted stock unit grants under the company’s stock incentive plan, and the Agreement in Principle to acquire Archenia, Inc. Other filings outline how Marchex uses non-GAAP measures such as adjusted EBITDA and adjusted non-GAAP income (loss) per share, together with reconciliations to GAAP metrics. The company’s proxy statement details matters for stockholder votes, such as the election of directors and ratification of the independent registered public accounting firm, and explains its dual-class common stock voting structure.
On Stock Titan, these SEC filings are updated from EDGAR and paired with AI-powered summaries that highlight key points, helping readers quickly understand the significance of lengthy documents. Users can review annual and quarterly reports for narrative discussion and financial disclosures, 8-Ks for material events, and proxy materials for governance and compensation information.
For those tracking insider and equity-related activity, filings related to stock incentive plans and director or executive compensation provide insight into option grants, RSUs, and change-in-control terms. By combining real-time access to Marchex’s official filings with AI-generated explanations, this page helps investors and analysts interpret how corporate actions, governance decisions, and strategic initiatives are reflected in the company’s regulatory record.
Marchex, Inc. files its annual report describing a business built around AI-powered conversation intelligence for enterprises that depend on phone calls, texts and other channels to acquire and serve customers, especially in B2B2C verticals like automotive and home services.
The company offers products such as Marketing Edge, Sonar Business Text Messaging, Marchex Platform Services, Spotlight, Engage, and AI-driven Call Summary and Sentiment Suite, all aimed at turning conversations into measurable sales and customer-experience improvements. It highlights growing use of generative AI, large language models and industry-specific analytics as key differentiators.
Marchex also discloses significant risk factors: an accumulated deficit of $331.4 million as of December 31, 2025, revenue concentration with the five largest customers representing about 36% of 2025 revenue, intense competition from larger technology and communications players, and evolving AI, privacy, telecommunications and TCPA regulations. As of March 19, 2026, the company had 4,660,927 Class A and 39,249,271 Class B shares outstanding and employed 139 full-time staff as of December 31, 2025.
Marchex, Inc. reported lower 2025 results but highlighted improving underlying profitability and a planned AI-focused acquisition. GAAP revenue was $10.8 million in Q4 2025 versus $11.9 million a year earlier, with full-year 2025 revenue of $45.4 million versus $48.1 million. Net loss was $2.3 million in Q4 2025 and $5.2 million for 2025, slightly wider than 2024. However, adjusted EBITDA was a loss of $0.7 million for 2025, and excluding $2.6 million of reorganization and acquisition-related costs, management indicates adjusted EBITDA would have been a $1.9 million gain.
For 2026, Marchex anticipates Q1 revenue roughly in line with Q4 2025 and adjusted EBITDA of at least $500,000, rising to more than $1 million in Q2 as revenue grows sequentially. Management targets 2026 revenue run-rate growth of about 10% from 2025 year-end levels and adjusted EBITDA margins of 10% or more. Marchex also updated progress on its proposed acquisition of Archenia, Inc., which estimates more than $17 million of 2025 revenue with positive adjusted EBITDA, and projects the potential combined company could reach approximately $60 million in annualized revenue in 2026 with 15–20% growth.
Marchex Inc. President & Chief Revenue Officer Troy Hartless exercised restricted stock units and received Class B common shares. On March 20, 2026, 87,500 restricted stock units converted into 87,500 shares of Class B Common Stock at a price of $0.00 per share. These units were granted effective March 20, 2025 and vested in full on the first anniversary of the grant date, making this a compensation-related equity delivery rather than an open-market purchase or sale. Following the conversion, this award’s derivative position is fully exercised and Hartless holds 87,500 Class B shares from this grant.
Marchex Inc Chief Financial Officer Brian Nagle exercised 7,500 restricted stock units into 7,500 shares of Class B Common Stock. The Form 4 shows a derivative exercise (code M) on March 20, 2026 at a stated price of $0.00 per unit.
According to the footnote, these restricted stock units were granted effective March 20, 2025 and vested in full on the first anniversary of the grant date. After the settlement, Nagle directly holds 7,500 shares of Class B Common Stock and no remaining units from this award. The filing reports no share sales or tax-withholding dispositions, indicating a routine compensation-related vesting and share issuance.
Marchex Inc. Chief Operating Officer & CLO Francis J. Feeney exercised 62,500 restricted stock units into the same number of Class B Common Stock shares. The units, granted effective March 20, 2025, vested in full on the first anniversary and converted at a zero exercise price as part of his equity compensation.
Marchex, Inc. approved new restricted stock unit grants for three senior executives as part of its annual compensation review. On February 17, 2026, Troy Hartless received 128,205 RSUs, Francis Feeney received 96,153 RSUs, and Brian Nagle received 56,089 RSUs.
Each RSU converts into one share of Class B Common Stock and vests in full on the first anniversary of the grant date, aligning these executives’ compensation with future company performance over the next year under the 2021 Stock Incentive Plan.
Nagle Brian reported acquisition or exercise transactions in this Form 4 filing.
Marchex Inc Chief Financial Officer receives new equity award. Brian Nagle was granted 56,089 restricted stock units effective February 17, 2026. The award was recorded at a price of $0.00 per unit, reflecting a non-cash grant.
Each restricted stock unit represents the right to receive one share of Marchex Class B common stock upon vesting. The units vest in full on the first anniversary of the grant date, meaning all 56,089 units are scheduled to vest one year after February 17, 2026, if conditions are met.
Marchex Inc reported an equity compensation grant to a senior executive. President & Chief Revenue Officer Troy Hartless acquired 128,205 restricted stock units effective February 17, 2026. Each unit represents one share of Class B common stock and will vest in full on the first anniversary of the grant date, increasing his direct equity-based stake if vesting conditions are satisfied.
Feeney Francis J reported acquisition or exercise transactions in this Form 4 filing.
Marchex Inc. reported that Chief Operating Officer & Chief Legal Officer Francis J. Feeney received a grant of 96,153 restricted stock units effective February 17, 2026. Each unit represents one share of Class B common stock and will vest in full on the first anniversary of the grant date, aligning his compensation with future company performance.
Marchex, Inc. approved annual cash bonuses for its senior executives for fiscal year 2025. The Compensation Committee granted a $200,000 bonus to President and Chief Revenue Officer Troy Hartless, $150,000 to Chief Operating Officer, Chief Legal Officer, and Corporate Secretary Francis Feeney, and $40,000 to Chief Financial Officer Brian Nagle.